Diligence memo · auto-generated · as of July 2, 2026
FCA Health Innovations II, LP
FCA Health Innovations II, LP looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
FCA Health Innovations II, LP operates in Healthtech, based in Brentwood.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
FCA Health Innovations II, LP has raised $8.5M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $8.5M on 2020-11-03.
Most recent recorded round closed around 2020-11-03.
Valuation (modeled)modeled
Provath models FCA Health Innovations II, LP at approximately $168M (range $11M–$844M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.43× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era. Within the normal band (143% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 5.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 66% of Healthtech peers (2138 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.